| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 23 |
| 1 | AMLODIPINE | 15 |
| 2 | BISOPROLOL FUMARATE | 15 |
| 3 | ASPIRIN | 14 |
| 4 | ASPIRIN 325 MG | 14 |
| 5 | ASPIRIN 81 MG | 14 |
| 6 | FUROSEMIDE | 12 |
| 7 | METOPROLOL | 11 |
| 8 | METOPROLOL TARTRATE | 11 |
| 9 | RIVAROXABAN | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIVMECILLINAM | 1 | 0.0053 |
| 1 | MEXILETINE HYDROCHLORIDE | 2 | 0.0048 |
| 2 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 3 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 4 | TRIAZOLAM | 6 | 0.0015 |
| 5 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 6 | MEBENDAZOLE | 1 | 0.0013 |
| 7 | DALBAVANCIN | 1 | 0.0010 |
| 8 | FLUOCINOLONE ACETONIDE | 3 | 0.0008 |
| 9 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 33 |
| 1 | Benzodiazepine [EPC] | 22 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 20 |
| 4 | Corticosteroid [EPC] | 19 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 17 |
| 6 | Calcium Channel Blocker [EPC] | 15 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 15 |
| 8 | Loop Diuretic [EPC] | 14 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | Anthelmintic [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 3 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 5 | 0.0002 |
| 4 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Interleukin-17A Antagonist [EPC] | 5 | 0.0001 |
| 8 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |
| 9 | Factor Xa Inhibitor [EPC] | 33 | 0.0001 |